Compare Novartis AG (NVS) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.7. The key difference: Novartis AG pays a 3.17% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and Novartis AG is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| NVS | XDTE | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $168.62 | $44.76 |
52-Week Low | $113.50 | $36.00 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
